Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-25-043232
Filing Date
2025-09-30
Accepted
2025-09-30 16:19:43
Documents
116
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 6-K nbx-20250630.htm   iXBRL 6-K 1743592
  Complete submission text file 0001628280-25-043232.txt   11416621

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nbx-20250630.xsd EX-101.SCH 116897
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nbx-20250630_cal.xml EX-101.CAL 102067
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nbx-20250630_def.xml EX-101.DEF 414886
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nbx-20250630_lab.xml EX-101.LAB 794097
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nbx-20250630_pre.xml EX-101.PRE 640047
118 EXTRACTED XBRL INSTANCE DOCUMENT nbx-20250630_htm.xml XML 2285064
Mailing Address 60 RUE DE WATTIGNIES PARIS I0 75012
Business Address 60 RUE DE WATTIGNIES PARIS I0 75012 33140260470
Nanobiotix S.A. (Filer) CIK: 0001760854 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39777 | Film No.: 251360722
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)